(Q40875040)

24 September 2017

1 reference

title

Modulation of interleukin-6/interleukin-6 receptor cytokine loop in the treatment of multiple myeloma (English)

1 reference

24 September 2017

Chen YH

1

1 reference

24 September 2017

Shiao RT

2

1 reference

24 September 2017

Labayog JM

3

1 reference

24 September 2017

Modi S

4

1 reference

24 September 2017

Lavelle D

5

1 reference

24 September 2017

1 September 1997

1 reference

24 September 2017

1 reference

24 September 2017

27

1 reference

24 September 2017

1-2

1 reference

24 September 2017

11-23

1 reference

The treatment of multiple myeloma

24 September 2017

1 reference

https://api.crossref.org/works/10.3109%2F10428199709068267

Interleukin 6 gene expression in normal and neoplastic B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709068267

Interleukin-6 antisense oligonucleotides inhibit the growth of human myeloma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709068267

Serum levels of interleukin 6, a potent myeloma cell growth factor, as a reflect of disease severity in plasma cell dyscrasias

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709068267

Interleukin 3 and interleukin 6 synergistically promote the proliferation and differentiation of malignant plasma cell precursors in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709068267

Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709068267

Recruitment of new osteoblasts and osteoclasts is the earliest critical event in the pathogenesis of human multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709068267

Evidence for the secretion of an osteoclast stimulating factor in myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709068267

Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709068267

Disruption by interferon-alpha of an autocrine interleukin-6 growth loop in IL-6-dependent U266 myeloma cells by homologous and heterologous down-regulation of the IL-6 receptor alpha- and beta-chains

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709068267

Interferon-alpha down-regulates the interleukin-6 receptor in a human multiple myeloma cell line, U266.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709068267

Interferon-gamma in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709068267

Response rate and survival in myeloma patients receiving prednisone alone.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709068267

Dexamethasone and suramin inhibit cell proliferation and interleukin-6-mediated immunoglobulin secretion in human lymphoid and multiple myeloma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709068267

Mechanisms of inhibition of IL-6-mediated immunoglobulin secretion by dexamethasone and suramin in human lymphoid and myeloma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709068267

Suramin interferes with interleukin-6 receptor binding in vitro and inhibits colon-26-mediated experimental cancer cachexia in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709068267

Effects of suramin on in vitro growth of fresh human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709068267

Anti-human interleukin-6 receptor antibody inhibits human myeloma growth in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709068267

Hypercalcaemia and increased serum interleukin-6 levels induced by all-trans retinoic acid in patients with multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709068267

Usefulness of flow cytometric detection of cell surface interleukin-6 receptors in human myeloma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709068267

Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709068267

10.3109/10428199709068267

21 January 2018

Identifiers

DOI

1 reference

24 September 2017

1 reference